학술논문

Adjuvant denosumab in postmenopausal patients with hormone receptor-positive breast cancer (ABCSG-18): disease-free survival results from a randomised, double-blind, placebo-controlled, phase 3 trial
Document Type
Article
Source
In: The Lancet Oncology. (The Lancet Oncology, March 2019, 20(3):339-351)
Subject
Language
English
ISSN
14745488
14702045